Medical economics

COVID-19 vaccine nationalism could cost world up to $1.2 trillion

Nationalistic behavior by governments may exclude some countries from gaining access to COVID-19 vaccines and cost the global economy up to $1.2 trillion a year in GDP, according to a new study from the not-for-profit research ...

Vaccination

200 mn Covid vaccine doses pledged for 'equitable' use

Drugmakers Sanofi and GSK said Wednesday they would set aside 200 million doses of a future coronavirus vaccine for a global initiative to ensure equitable distribution, including in poor countries.

Vaccination

AstraZeneca, Oxford Uni buoyed by vaccine response

British pharma giant AstraZeneca said on Monday trials of its coronavirus vaccine pioneered with Oxford University had shown "encouraging" responses among elderly, as well as younger participants.

Obstetrics & gynaecology

Mayo Clinic Q&A: Adolescents and gynecologic health

My daughter is 14 and her pediatrician recently reminded us that she should get the HPV vaccine because it can help prevent cervical cancer. That got me thinking about gynecologic health for my daughter. Are there conditions ...

Diseases, Conditions, Syndromes

Israel says to trial COVID-19 vaccine from next month

Israel will begin its first clinical trials of a novel coronavirus vaccine next month, authorities said Sunday, as the country grapples with a second wave of infections.

Diseases, Conditions, Syndromes

AstraZeneca, J&J vaccine trials back on track in US

Two major clinical trials for experimental COVID-19 vaccines got back on track in the United States Friday—providing a glimmer of hope as the number of cases skyrocket across the country.

page 2 from 13